温度敏感型液体栓塞剂在肝肿瘤介入治疗中的应用研究进展
Research Progress on the Application of Temperature Sensitive Liquid Embolic Agents in Interventional Treatment of Liver Tumors
DOI: 10.12677/acm.2026.1662346, PDF,    科研立项经费支持
作者: 曾 瑜:重庆医科大学附属永川医院重症监护室,重庆;罗彬文, 李 鹤*:重庆市永川区人民医院肝胆外科,重庆
关键词: 温度敏感型液体栓塞剂肝脏肿瘤介入治疗Temperature Sensitive Liquid Embolic Agent Liver Tumor Interventional Therapy
摘要: 近年来,介入治疗领域取得长足进步,已成为中晚期及不可切除肝脏肿瘤的主要治疗方式之一,而栓塞材料的创新与发展是技术进步的关键。温度敏感型液体栓塞剂(TempSLE)是一类可在体温下发生溶胶–凝胶相变的新型生物材料,近年来在肝脏肿瘤介入治疗领域受到了越来越多的关注。与传统的碘油等栓塞剂相比,这类材料既能经导管顺利注入,又能在血管内快速固化形成持久栓塞,在肝脏肿瘤介入治疗中展现出一定的优势。然而,目前该领域仍存在不少争议与挑战,如部分材料的力学强度不足、体内降解途径不明确、功能复合型材料难以制备等问题,以及缺乏大样本、多中心的前瞻性临床证据。本文系统综述TempSLE的基础特性及分类,阐述其在肝脏肿瘤介入治疗中的应用进展,评价其疗效与安全性,并分析临床转化挑战与发展方向,以期为该类材料的进一步研究及肝脏肿瘤精准介入治疗提供理论参考。
Abstract: In recent years, significant progress has been made in the field of interventional therapy, which has become one of the main treatment methods for mid-to-late stage and unresectable liver tumors. The innovation and development of embolic materials are key to technological advancement. Temperature-sensitive liquid embolic agents (TempSLE) are a class of novel biomaterials. They can undergo sol-gel phase transition at body temperature. In recent years, they have received increasing attention in the field of interventional therapy for liver tumors. Compared with traditional embolic agents such as lipiodol, these materials can be smoothly delivered through catheters. They can also rapidly solidify into durable emboli within blood vessels. Therefore, they show certain advantages in liver tumor interventional therapy. However, there are still many controversies and challenges in this field. For example, some materials have insufficient mechanical strength. The degradation pathways of these materials are unclear. Functional composite materials are difficult to prepare. Moreover, there is a lack of large-scale, multicenter prospective clinical evidence. This article systematically reviews the basic properties and classifications of TempSLE. It describes their application progress in interventional therapy for liver tumors. It evaluates their efficacy and safety. It also analyzes challenges in clinical translation and future directions. The goal is to provide a theoretical reference for further research on these materials and for precision interventional therapy of liver tumors.
文章引用:曾瑜, 罗彬文, 李鹤. 温度敏感型液体栓塞剂在肝肿瘤介入治疗中的应用研究进展[J]. 临床医学进展, 2026, 16(6): 1358-1364. https://doi.org/10.12677/acm.2026.1662346

参考文献

[1] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[2] Lanza, E., Donadon, M., Poretti, D., Pedicini, V., Tramarin, M., Roncalli, M., et al. (2016) Transarterial Therapies for Hepatocellular Carcinoma. Liver Cancer, 6, 27-33. [Google Scholar] [CrossRef] [PubMed]
[3] Chang, Y., Jeong, S.W., Young Jang, J. and Jae Kim, Y. (2020) Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma. International Journal of Molecular Sciences, 21, Article 8165. [Google Scholar] [CrossRef] [PubMed]
[4] Li, J., Xian, L., Wang, X., Liu, Y. and Li, J. (2025) The Role of TACE in the Era of Immune-Targeted Therapy for Hepatocellular Carcinoma: A Meta-Analysis Based on PSM. Frontiers in Immunology, 16, Article ID: 1573834. [Google Scholar] [CrossRef] [PubMed]
[5] Kim, Y.R., Kim, E., Kim, H.I., Han, S., An, J. and Shim, J.H. (2025) Updated Network Meta-Analysis of First-Line Systemic Treatments for Advanced HCC: Consistent Role of TACE. Liver Cancer, 15, 117-134. [Google Scholar] [CrossRef] [PubMed]
[6] 陈宁, 郭安然, 谢文静, 等. 新型液体栓塞剂在肝癌中的基础研究现状与进展[J]. 湖北科技学院学报(医学版), 2023, 37(5): 448-453.
[7] Liu, Y., Liu, J., Zheng, C. and Ma, Z. (2026) Recent Advances in Embolic Agents for Transarterial Chemoembolization of Hepatocellular Carcinoma. Advanced Healthcare Materials, 15, e2566. [Google Scholar] [CrossRef
[8] 靳勇, 张昊, 程永德. 液体栓塞剂应用及其研究进展[J]. 介入放射学杂志, 2025, 34(12): 1285-1292.
[9] Chen, G., Wei, R., Huang, X., Wang, F. and Chen, Z. (2020) Synthesis and Assessment of Sodium Alginate-Modified Silk Fibroin Microspheres as Potential Hepatic Arterial Embolization Agent. International Journal of Biological Macromolecules, 155, 1450-1459. [Google Scholar] [CrossRef] [PubMed]
[10] Shi, D., Ren, Y., Liu, Y., Yan, S., Zhang, Q., Hong, C., et al. (2024) Temperature-Sensitive Nanogels Combined with Polyphosphate and Cisplatin for the Enhancement of Tumor Artery Embolization by Coagulation Activation. Acta Biomaterialia, 185, 240-253. [Google Scholar] [CrossRef] [PubMed]
[11] Li, X., Ullah, M.W., Li, B. and Chen, H. (2023) Recent Progress in Advanced Hydrogel‐Based Embolic Agents: From Rational Design Strategies to Improved Endovascular Embolization. Advanced Healthcare Materials, 12, e2202787. [Google Scholar] [CrossRef] [PubMed]
[12] Hwang, H., Kim, K.I., Kwon, J., Kim, B.S., Jeong, H., Jang, S.J., et al. (2017) 131 I-Labeled Chitosan Hydrogels for Radioembolization: A Preclinical Study in Small Animals. Nuclear Medicine and Biology, 52, 16-23. [Google Scholar] [CrossRef] [PubMed]
[13] Hatlevik, Ø., Jensen, M., Steinhauff, D., Wei, X., Huo, E., Jedrzkiewicz, J., et al. (2022) Translational Development of a Silk‐Elastinlike Protein Polymer Embolic for Transcatheter Arterial Embolization. Macromolecular Bioscience, 22, e2100401. [Google Scholar] [CrossRef] [PubMed]
[14] Zhao, H., Zheng, C., Feng, G., Zhao, Y., Liang, H., Wu, H., et al. (2013) Temperature-Sensitive Poly(N-Isopropylacrylamide-Co-Butyl Methylacrylate) Nanogel as an Embolic Agent: Distribution, Durability of Vascular Occlusion, and Inflammatory Reactions in the Renal Artery of Rabbits. American Journal of Neuroradiology, 34, 169-176. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, L., Yu, S., Duan, Z., Wang, Q., Tian, G., Tian, Y., et al. (2013) Treatment of Liver Cancer in Mice by the Intratumoral Injection of an Octreotide-Based Temperature-Sensitive Gel. International Journal of Molecular Medicine, 33, 117-127. [Google Scholar] [CrossRef] [PubMed]
[16] Zhou, H., Xie, W., Guo, A., Chen, B., Hu, S., Zheng, M., et al. (2023) Temperature Sensitive Nanogels for Real-Time Imaging during Transcatheter Arterial Embolization. Designed Monomers and Polymers, 26, 31-44. [Google Scholar] [CrossRef] [PubMed]
[17] Poursaid, A., Price, R., Tiede, A., Olson, E., Huo, E., McGill, L., et al. (2015) In Situ Gelling Silk-Elastinlike Protein Polymer for Transarterial Chemoembolization. Biomaterials, 57, 142-152. [Google Scholar] [CrossRef] [PubMed]
[18] Cornelis, F.H. and Solomon, S.B. (2018) Treatment of Primary Liver Tumors and Liver Metastases, Part 2: Non–nuclear Medicine Techniques. Journal of Nuclear Medicine, 59, 1801-1808. [Google Scholar] [CrossRef] [PubMed]
[19] Zhou, C., Shi, Q., Liu, J., Huang, S., Yang, C. and Xiong, B. (2020) Effect of Inhibiting Tumor Angiogenesis after Embolization in the Treatment of HCC with Apatinib-Loaded P(N-Isopropyl-Acrylamide-Co-Butyl Methyl Acrylate) Temperature-Sensitive Nanogel. Journal of Hepatocellular Carcinoma, 7, 447-456. [Google Scholar] [CrossRef] [PubMed]
[20] Qian, K., Ma, Y., Wan, J., Geng, S., Li, H., Fu, Q., et al. (2015) The Studies about Doxorubicin-Loaded P(N-Isopropyl-Acrylamide-Co-Butyl Methylacrylate) Temperature-Sensitive Nanogel Dispersions on the Application in TACE Therapies for Rabbit VX2 Liver Tumor. Journal of Controlled Release, 212, 41-49. [Google Scholar] [CrossRef] [PubMed]
[21] Li, Y., Ge, X., Li, Z., Zhou, Z., Wu, K., Li, Y., et al. (2024) Application of Temperature-Sensitive Liquid Embolic Agent Loaded with Oxaliplatin in the TACE Procedure for Rabbit VX2 Gastric Cancer. Drug Delivery and Translational Research, 14, 705-717. [Google Scholar] [CrossRef] [PubMed]
[22] Santhamoorthy, M., Vy Phan, T.T., Ramkumar, V., Raorane, C.J., Thirupathi, K. and Kim, S. (2022) Thermo-Sensitive Poly (N-Isopropylacrylamide-Co-Polyacrylamide) Hydrogel for Ph-Responsive Therapeutic Delivery. Polymers, 14, 4128. [Google Scholar] [CrossRef] [PubMed]
[23] Li, X., Liu, W., Ye, G., Zhang, B., Zhu, D., Yao, K., et al. (2005) Thermosensitive-Isopropylacrylamide—Propylacrylamide-Vinyl Pyrrolidone Terpolymers: Synthesis, Characterization and Preliminary Application as Embolic Agents. Biomaterials, 26, 7002-7011. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, Z., Deng, X., Ding, J., Zhou, W., Zheng, X. and Tang, G. (2018) Mechanisms of Drug Release in Ph-Sensitive Micelles for Tumour Targeted Drug Delivery System: A Review. International Journal of Pharmaceutics, 535, 253-260. [Google Scholar] [CrossRef] [PubMed]
[25] Xie, X., Wang, Y., Deng, B., Blatchley, M.R., Lan, D., Xie, Y., et al. (2024) Matrix Metalloproteinase-Responsive Hydrogels with Tunable Retention for On-Demand Therapy of Inflammatory Bowel Disease. Acta Biomaterialia, 186, 354-368. [Google Scholar] [CrossRef] [PubMed]
[26] Hagan, A., Caine, M., Press, C., Macfarlane, W.M., Phillips, G., Lloyd, A.W., et al. (2019) Predicting Pharmacokinetic Behaviour of Drug Release from Drug-Eluting Embolization Beads Using in Vitro Elution Methods. European Journal of Pharmaceutical Sciences, 136, Article 104943. [Google Scholar] [CrossRef] [PubMed]
[27] Dethe, M.R., A, P., Ahmed, H., Agrawal, M., Roy, U. and Alexander, A. (2022) PCL-PEG Copolymer Based Injectable Thermosensitive Hydrogels. Journal of Controlled Release, 343, 217-236. [Google Scholar] [CrossRef] [PubMed]
[28] Hong, C., Liu, Y., Shi, D., Liu, C., Zou, S., Guo, M., et al. (2024) Radiofrequency-Responsive Black Phosphorus Nanogel Crosslinked with Cisplatin for Precise Synergy in Multi-Modal Tumor Therapies. Journal of Controlled Release, 373, 853-866. [Google Scholar] [CrossRef] [PubMed]
[29] Chen, X., Xiao, H., Lan, X. and Du, C. (2026) Clinical Efficacy Exploration of Temperature-Sensitive Embolic Agent TACE Combined with HAIC and Targeted/Immunotherapy for Unresectable Primary Liver Cancer. Journal of Hepatocellular Carcinoma, 13, 1-10. [Google Scholar] [CrossRef
[30] 陈冠群, 陈尚忠, 王正安. 新型温度敏感型液体栓塞剂对比传统碘化油栓塞剂在不可切除原发性肝癌经导管动脉化疗栓塞术治疗中的疗效及安全性[J]. 系统医学, 2025, 10(24): 174-177.
[31] 郝俊山, 桑雨, 尚建南, 等. 新型温度敏感型液体栓塞剂经皮肝动脉化疗栓塞术治疗不可切除原发性肝癌的短期疗效及安全性分析[J]. 中国医刊, 2025, 60(9): 1109-1115.
[32] Zhou, S., Lin, Q., Zhong, J. and Chen, J. (2025) An Analysis of the Clinical Efficacy and Safety of a Temperature-Sensitive Liquid Embolic Agent Loaded with Lobaplatin for the Treatment of Unresectable Primary Hepatocellular Carcinoma through Chemoembolization. Journal of Cancer Research and Therapeutics, 21, 504-508. [Google Scholar] [CrossRef] [PubMed]
[33] Lin, F., Chen, Q., Gao, M., Ji, Y., Ruan, D., Zhang, J., et al. (2024) Retrospective Observation of the Early Efficacy and Safety of Temperature-Sensitive Liquid Embolic Agent Combined with Polyvinyl Alcohol Microspheres for Prostatic Artery Embolization in the Treatment of Lower Urinary Tract Symptoms Caused by Benign Prostatic Hyperplasia. Translational Andrology and Urology, 13, 1847-1858. [Google Scholar] [CrossRef] [PubMed]